Brief: Ligand Acquires Royalty On Sanofi’S Tzield® For $20 Million

Ligand Pharmaceuticals Incorporated

01/11/2023 12:03

Nov 1 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND ACQUIRES ROYALTY ON SANOFI’S TZIELD® FOR $20
MILLION
    * LIGAND ACQUIRES ROYALTY ON SANOFI’S TZIELD® FOR $20
MILLION
    * LIGAND PHARMACEUTICALS INC: TRANSACTION WILL BE
IMMEDIATELY
ACCRETIVE TO LIGAND'S ROYALTY REVENUE
    * LIGAND PHARMACEUTICALS INC - LIGAND ACQUIRES ROYALTY ON
SANOFI'S
TZIELD FOR $20 MILLION

Source text for Eikon:  ID:nBw4zNxR6a 
Further company coverage:  LGND.O 

 ((Reuters.Briefs@thomsonreuters.com;))